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SIP 1: Increasing the overall epidemic vaccination coverage
Epidemic vaccination coverage: It’s a long way to Tipperary!
Vaccination is one of the best ways to ﬁght epidemic inﬂuenza.
In fact, according to Dr. Kristin Nichol of the Minneapolis VAMedi-
cal Center, “inﬂuenza is the #1 vaccine preventable disease among
adults in the US, accounting for 500,000 deaths each year.” More-
over, the disease burden is huge. Of all vaccine preventable deaths
in the US, 99% afﬂict adults and most of these are due to inﬂuenza.
Moreover, two-thirds of mortality occurs among people 65 and
olderwhoaredischarged fromhospital during theﬂu season.While
the data is from the US, the situation is similar throughout most of
the developed world.
Inﬂuenza is thenumberone causeof vaccinepreventabledeaths
in the US
With such a compelling reason to increase vaccination cover-
age, the World Health Organisation (WHO) advocates vaccination
of those over 65 years of age, the immuno-compromised or persons
suffering from chronic illnesses such as cardiovascular, respiratory,
metabolic and/or renal disease, and healthcare workers. The WHO
has also set target coverage rates of 50% by 2006 and 75% by 2010
for the elderly.Whilemany countries support theWHO guidelines,
the speciﬁc WHO targets have so far only been achieved by one
country, the United Kingdom.
“Vaccination is the mainstay of prevention and control,
but vaccination is under-utilised. US vaccination rates
have been stagnant for nearly a decade.”—Dr. Kristin
Nichol, Minneapolis VA Medical Center
Disease Cases Deaths
Inﬂuenza (millions) >500,000a
Pneumococcal (millions) ∼120,000
Hepatitis A 282,650 1,013
Hepatitis B 146,644 9,694
Measles 60,189 132
Mumps 24,075 7
Rubella 4412 21
Pertussis 53,634 65
Tetanus 486 77
a 90% in the elderly.
Vaccination is the mainstay of prevention and control,” states
Nichol, “but vaccination is under-utilised.USvaccination rates have
been stagnant for nearly a decade.” There is clearly much room for
improvement.
Source: MMWR 2001;50(25):532–37; NHIS (01, 03, January–
June 2005).
Current coverage: all over the map
Several studies have attempted to track progress in epidemic
vaccination coverage.
A large study examined seasonal inﬂuenza vaccination in
Europe. The study was conducted by TNS Healthcare (and Groupe
d’Etude et d’Information sur la Grippe in France). Researchers
surveyed 22,000 people over the age of 14 in 11 European
countries.
According to Dr. Thomas Szucs of the University of Zurich, the
resultswerenot encouraging. The researchers found little improve-
ment from 2007 to 2008, and in some instances vaccination rates
were even lower than the previous year. Moreover, there are huge
variations in the rate of coverage, with Poland at one end of the
spectrum (16%) and theUKat the other (78%). Gaps are even greater
for groups under the age of 65, and the vaccination coverage of
healthcare workers is even lower, with a high in the UK of only 29%
and a low in Poland of 9%. Furthermore, good intentions are not
enough. “The number of people saying that they intend to get vacci-
nated tends to behigher than the number of peoplewho actually do
get vaccinated,” states Szucs, “positive intentions do not translate
into actual coverage.”
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Research results from a study by the “Macroepidemiology of
inﬂuenza vaccination study group” (MIVSG) aremore encouraging.
Although great differences persist, countries also showed extreme
growth in coverage, increasing to292milliondoses in 2003and329
million doses in 2005. “This represents progress no matter where
you are,” says Dr. David Fedson, a French-based inﬂuenza expert.
The MIVSG is a voluntary, unfunded network of individuals in
73 countries who report on inﬂuenza vaccine distribution. Every
region of the world is represented in the network, although some
regions, such as North America and Europe, aremore fully covered.
The MIVSG study measured doses distributed from 1997 to 2005
worldwide. Because it measured doses distributed and not actual
vaccinations theremaybe someover-reporting (because theremay
have been some wastage). Nonetheless, the research gives some
clear indications.
As with the TNS study, the MIVSG found extraordinary vari-
ation across countries, in terms of vaccination rates as well as
vaccination policies.Most countries vaccinate the over 60–65 years
age group and those with complications such as renal disease, a
cardiopulmonary condition, diabetes mellitus or immunocompro-
mise. YetAustria vaccinates thosewhoare 50years andolder. Some
countries vaccinate children up to 2 years of age, while the US rec-
ommendation is that children be vaccinated up to the age of 18.
Moreover, vaccination of children does not follow overall trends in
a country.
“It is difﬁcult to discern clear reasons for the variation between
countries,” says Fedson. “Manynon-producing countries, for exam-
ple, use vaccine at rates exceeding those in producing countries.
So, the availability or non-availability of supply is apparently not a
determining factor in vaccine consumption.”
Factors which encourage vaccination: “It’s the healthcare
worker again. . .”
With so much variation across countries and no obvious expla-
nations for the variation, researchers attempted to ﬁnd answers.
The TNS Healthcare survey sought to determine which factors
encourage vaccination. “It was an almost sociological exercise in
trying to ﬁnd out why people get vaccinated and why they don’t,”
states Szucs.
“Researchers for the MIVSG in the US discovered that
when a doctor or nurse recommended vaccination to
positively predisposed patients, 87% of patients got
vaccinated. Moreover, even when the patients had a
negative attitude towards vaccination 70% of them
still got vaccinated if their healthcare provider recom-
mended it.”
The main conclusion of the research conﬁrmed what experts
have always believed: the role of the healthcare worker is crucial.
Researchers for the MIVSG in the US discovered that when a doc-
tor or nurse recommended vaccination to positively predisposed
patients, 87% of patients got vaccinated. Moreover, even when the
patients had a negative attitude towards vaccination 70% of them
still got vaccinated if their healthcare provider recommended it. In
contrast, when patients had a positive attitude but their physician
didnot recommendvaccination, only8%got vaccinated.Aproactive
healthcare worker, therefore, has a huge impact on the likelihood
of a patient getting vaccinated.
“A provider recommendation can even help negatively
disposed patients, and a provider’s recommendation
is a ‘freebie’ – it doesn’t cost the system much.”—Dr.
Kristin Nichol, Minneapolis VA Medical Center
“A provider recommendation can even help negatively disposed
patients,” states Dr. Nichol, “and a provider’s recommendation is a
‘freebie’ – it doesn’t cost the system much.” As with the MIVSG
study, Nichol found that when doctors recommended vaccination
to negatively disposed patients, they were more likely to get vac-
cinated (82%) than when they received no recommendation (27%).
Source: Nichol KL et al. J Gen Intern Med 1996;11:673.
Nichol offers several ways in which healthcare providers can
promote vaccination. The most obvious starting points are that
physicians and nurses should know the facts, such as when to rec-
ommendvaccination, and that they should proactively recommend
vaccination. Nichol has several more original suggestions, as well,
however. She believes that physicians should put in place systems
that promote vaccination or “automate the offering”, as she calls
it. Physicians could, for example, automate processes to empower
nurses. A standing order from a physician that authorises nurses to
vaccinate is one example of such “systems approaches”.
In a randomised trial of 3777 patients discharged between
1 November 1998 and 31 December 1999 in Indianapolis dur-
ing the ﬂu season, 50% of inpatients were eligible for inﬂuenza
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vaccinations. For the standing orders group, the computer gen-
erated a computerised order for nurses to vaccinate at the time
of discharge. For the reminder group, the computer provided
reminders to doctors that included vaccine orders (a pop-up
reminderwith an order, but it required 1 keystroke+ F8+user pass-
word). The reminder group received an average of 5.3 reminders
during the patient stay.
Patients from the standing orders group were 16 percentage
pointsmore likely toget vaccinated for inﬂuenza thanpatients from
the reminders group.
“. . .fewer than half of all patients are vaccinated at doc-
tor’s ofﬁces, other important venues are walk-in clinics,
work sites and even grocery stores or pharmacies.”—Dr.
Kristin Nichol, Minneapolis VA Medical Center
We should also offer vaccination in non-traditional venues,
according to Nichol. “Doctors are the biggest slice of the pie,” says
Nichol, “but fewer thanhalf of all patients are vaccinated at doctor’s
ofﬁces, other important venues are walk-in clinics, work sites and
even grocery stores or pharmacies.”
Healthcare providers should also use patient reminders and
other strategies to increase patient demand for vaccination. They
can keep better records and monitor the number of vaccinations.
Providers tend to overestimate the number of patients they have
actually vaccinated, according to Nichol.
“Healthcare workers who are themselves vaccinated
are more likely to vaccinate their patients.”—Dr. Kristin
Nichol, Minneapolis VA Medical Center
Above all, Nichol believes that we should “practice what we
preach”. Healthcare workers should follow the maxim of “ﬁrst do
noharm”. They can reduce the risk of transmitting inﬂuenza to their
patients by getting vaccinated themselves. Moreover, although the
causality is unclear, there is a correlation between the vaccination
status of healthcare workers and their patients. “Healthcare work-
ers who are themselves vaccinated are more likely to vaccinate
their patients,” says Nichol.
US Healthcare Worker vaccination rates
Source: NHIS.
Other ways to encourage vaccination
While undoubtedly important, focusing on the role of the
healthcare worker is not the only strategy for increasing vaccine
coverage. “We can capture missed opportunities by extending the
vaccination season,” states Nichol. The demand for vaccination
tends to spike well before the number of inﬂuenza cases spikes.
This suggests to Nichol that there are cases of inﬂuenza that could
still be prevented by vaccination.
Another strategy is to target hospitalised patients. According
to Nichol, hospitalisation is “a marker for increased risk”. More-
over, hospitalised patients may be less likely to be immunised.
Reimbursement and education are other important ways to
encourage vaccination that are frequently mentioned. The Univer-
sity of Zurich study found that lack of funding is correlated with
dramatically lower vaccination rates. Free or reimbursed vaccina-
tion, is not necessarily always the solution, however. Ultimately,
other factors as simple as the convenience of getting a vaccination
may play an important role.
How to increase coverage: the way forward
The level of vaccination coverage is the result of an interplay
among multiple factors: the commitment, motivation and organ-
isation of healthcare workers, policy decisions at the level of the
healthcare systemand the awareness and sophisticationof patients
themselves. Nonetheless, there are a number of overall strategies
which can make a difference. Aside from encouraging health-
care workers to proactively recommend vaccination, individual
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countries can also put in place speciﬁc policies such as improv-
ing coverage of individuals at risk and of children. On the level
of the healthcare provider, a study conducted in the US has
identiﬁed organisational change as by far the most important
factor.
Sharing information is also important. Being compared with
one’s neighbours is effective because of “the embarrassment fac-
tor”: countries are embarrassed if they are behind.
Ultimately, however, policies and strategies are only as effective
as the people who devise and implement them.
SIP 1: Increasing the overall epidemic vaccination coverage
15 September 2008
Chair:
Dr. A. Monto, University of Michigan, USA.
Speakers:
Dr. D. Fedson, France: Increasing the overall epidemic vaccination
coverage: the macroepidemiology of inﬂuenza vaccination.
Dr. T. Szucs, Institute of Social and PreventiveMedicine, University
of Zurich, Switzerland: Inﬂuenzavaccination coverage rates in four
European countries during the winter of 2007/08.
Dr. K. Nichol, Minneapolis VA Medical Center, USA: Maximising
seasonal inﬂuenza vaccination coverage.
